《MMWR,3月13日,Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-15
  • Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore — January 2–February 29, 2020

    Early Release / March 13, 2020 / 69

    Yixiang Ng, MSc1*; Zongbin Li, MBBS1*; Yi Xian Chua, MSc1; Wei Liang Chaw, MSc1; Zheng Zhao, MSc1; Benjamin Er, MSc1; Rachael Pung, MSc1; Calvin J. Chiew, MPH1; David C. Lye, MBBS2,3,4,5; Derrick Heng, MPH1; Vernon J. Lee, PhD1,6* (View author affiliations)

    Summary

    What is already known about this topic?

    First detected in China in late 2019, coronavirus disease 2019 (COVID-19) transmission has spread globally.

    What is added by this report?

    Singapore implemented a multipronged surveillance and containment strategy that contributed to enhanced case ascertainment and slowing of the outbreak. Based on review of the first 100 cases, the mean interval from symptom onset to isolation was 5.6 days and declined after approximately 1 month.

  • 原文来源:https://www.cdc.gov/mmwr/volumes/69/wr/mm6911e1.htm?s_cid=mm6911e1_e&deliveryName=USCDC_921-DM22175
相关报告
  • 《MMWR,3月6日,Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 — United States, January–February 2020》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-07
    • Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 — United States, January–February 2020 Weekly / March 6, 2020 / 69(9);245–246 On March 3, 2020, this report was posted online as an MMWR Early Release. Rachel M. Burke, PhD1; Claire M. Midgley, PhD1; Alissa Dratch, MPH2; Marty Fenstersheib, MD; Thomas Haupt, MS4; Michelle Holshue, MPH5,6; Isaac Ghinai, MBBS6,7; M. Claire Jarashow, PhD8; Jennifer Lo, MD9; Tristan D. McPherson, MD6,10; Sara Rudman, MD; Sarah Scott, MD6,12; Aron J. Hall, DVM1; Alicia M. Fry, MD1; Melissa A. Rolfes, PhD1 (View author affiliations) In December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2, began in Wuhan, China (1). The disease spread widely in China, and, as of February 26, 2020, COVID-19 cases had been identified in 36 other countries and territories, including the United States. Person-to-person transmission has been widely documented, and a limited number of countries have reported sustained person-to-person spread.* On January 20, state and local health departments in the United States, in collaboration with teams deployed from CDC, began identifying and monitoring all persons considered to have had close contact† with patients with confirmed COVID-19 (2). The aims of these efforts were to ensure rapid evaluation and care of patients, limit further transmission, and better understand risk factors for transmission.
  • 《Lancet,3月16日,Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-17
    • Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures Rachael Pung, MSc *Calvin J Chiew, MPH *Barnaby E Young, MB BChir,Sarah Chin, MPH Mark I-C Chen, PhD,Hannah E Clapham, PhD Published:March 16, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30528-6 Background Three clusters of coronavirus disease 2019 (COVID-19) linked to a tour group from China, a company conference, and a church were identified in Singapore in February, 2020. Methods We gathered epidemiological and clinical data from individuals with confirmed COVID-19, via interviews and inpatient medical records, and we did field investigations to assess interactions and possible modes of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Open source reports were obtained for overseas cases. We reported the median (IQR) incubation period of SARS-CoV-2.